Showing results (411-420 of 1,822) with videos related to

Sort By:
Pageof 183
Signal Transduction and Targeted Therapy|October 23, 2019
Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehiclesAkhand Pratap Singh, Arpan Biswas, Aparna Shukla, et al.
Signal Transduction and Targeted Therapy|June 10, 2026
Histaminylation alters collagen matrix mechanics and attenuates cardiac fibrosis post-myocardial infarction via mechanotransduction signaling axisJianfu Zhu, Dili Sun, Gaofeng Zeng, et al.
Signal Transduction and Targeted Therapy|June 9, 2026
Engineered tRNA reduces vision loss in a mouse model of Leber congenital amaurosisPawan K Shahi, Enes Akyuz, Lionel Gissot, et al.
Signal Transduction and Targeted Therapy|June 16, 2026
Targeting intracellular cholesterol imbalance rescues sarcomere-ER contact site signaling and ER remodeling in dilated cardiomyopathyNadezda Ignatyeva, Cleophas Cheruiyot, Hafiza Nosheen Saleem, et al.
Signal Transduction and Targeted Therapy|December 22, 2017
Transferrin protects against Parkinsonian neurotoxicity and is deficient in Parkinson's substantia nigraScott Ayton, Peng Lei, Catriona Mclean, et al.
Signal Transduction and Targeted Therapy|July 9, 2026
Multifunctional-engineered NK cells overcome tumor immunosuppression by combining PD-L1 and HLA-E targeting and endogenous IL15 productionPiera Filomena Fiore, Sergio Forcelloni, Lorenzo Moretta, et al.
Signal Transduction and Targeted Therapy|June 2, 2026
Intracellular logic computing with DNA tetrahedron processors enables precision cancer theranosticsYang Gao, Yun Wang, Yunlong Qin, et al.
Signal Transduction and Targeted Therapy|July 12, 2026
Tumor heterogeneity: development, mechanisms, and therapeutic implicationsJianhong Zhang, Heng Li, Shuo Ru, et al.
Signal Transduction and Targeted Therapy|July 1, 2026
Partial downregulation of platelet glycoprotein VI by low affinity antibodies confers sustained and safe antithrombotic protectionStefano Navarro, Sarah Beck, Sabrina I Bonfiglio, et al.
Signal Transduction and Targeted Therapy|July 1, 2026
Osimertinib-induced cardiotoxicity is driven by HDAC-dependent epigenetic repression and rescued by vorinostatAngelica Toro Cora, Arvind Singh Bhati, Allen Sam Titus, et al.
Pageof 183